PROCESSA PHARMACEUTICALS
Processa Pharmaceuticals operates as a pharmaceutical company. The company focuses on development of drug products that are intended to improve the survival and quality of life for patients who have unmet medical need.
PROCESSA PHARMACEUTICALS
Industry:
Automotive Biotechnology Computer Health Care Machinery Manufacturing
Founded:
2009-01-01
Address:
Hanover, Maryland, United States
Country:
United States
Website Url:
http://www.processapharmaceuticals.com
Total Employee:
11+
Status:
Active
Contact:
443-776-313
Email Addresses:
[email protected]
Total Funding:
15.58 M USD
Technology used in webpage:
Euro ReCAPTCHA ReCAPTCHA V2 Google Adsense
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Employees Featured
Founder
Stock Details
Key Employee Changes
Date | New article |
---|---|
2024-07-17 | Processa Pharmaceuticals appoints CFO |
2023-08-08 | Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer |
Official Site Inspections
http://www.processapharmaceuticals.com Semrush global rank: 6.67 M Semrush visits lastest month: 1.05 K
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149

More informations about "Processa Pharmaceuticals"
About :: Processa Pharmaceuticals, Inc. (PCSA)
Regulatory Science is What Sets Us Apart. We focus on acquiring de-risked, preclinical- and clinical-stage assets and applying our years of regulatory experience to navigate those โฆSee details»
Company Information :: Processa Pharmaceuticals, Inc.
Company Contact Processa Pharmaceuticals, Inc. 7380 Coca Cola Drive Suite 106 Hanover, MD 21076 T: 443.776.3133See details»
Processa Pharmaceuticals - LinkedIn
Processa Pharmaceuticals was founded in October 2017 with a mission to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need.See details»
Processa Pharmaceuticals Company Profile | Management and
Www.processapharmaceuticals.com Processa Pharmaceuticals Profile and History The mission of Processa is to develop products for which existing clinical evidence of efficacy has already โฆSee details»
Processa Pharmaceuticals - Crunchbase Company Profile & Funding
Processa Pharmaceuticals announced a $5 million public offering priced at-the-market under Nasdaq rules, involving 8,050,672 shares of common stock and accompanying Series A and B โฆSee details»
Processa Pharmaceuticals, Inc. - AnnualReports.com
Processa is a clinical stage pharmaceutical company focused on developing the Next Generation Chemotherapy (NGC) drugs to improve the safety and efficacy of cancer treatment.See details»
Processa Pharmaceuticals - VentureRadar
Website: https://processapharmaceuticals.com/ The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or ...See details»
Processa Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
Processa Pharmaceuticals contact info: Phone number: (443) 776-3133 Website: www.processapharmaceuticals.com What does Processa Pharmaceuticals do? The mission of โฆSee details»
Processa Pharmaceuticals CEO and Key Executive Team
Processa Pharmaceuticals's Chief Executive Officer, Interim Chief Financial Officer and Founder is David Young. Other executives include Wendy Guy, Chief Administrative Officer & Founder; โฆSee details»
Processa Pharmaceuticals - Craft
Oct 29, 2024 Processa Pharmaceuticals (formerly Heatwurx) is a company focused on developing treatments for patients with an unmet medical need. Its product candidate, โฆSee details»
Investor Relations :: Processa Pharmaceuticals, Inc. (PCSA)
Jan 30, 2025 The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options โฆSee details»
Processa Pharmaceuticals - Products, Competitors, Financials, โฆ
Headquarters Location. 7380 Coca Cola Drive Suite 106. Hanover, Maryland, 21076, United States. 443-776-3133See details»
Processa Pharmaceuticals, Inc. Company Information
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. โฆSee details»
Management Team :: Processa Pharmaceuticals, Inc. (PCSA)
Russell L. Skibsted. Chief Financial Officer. Mr. Skibsted brings to Processa nearly 30 years of experience in the pharmaceutical industry, including expertise in financial management, global โฆSee details»
Processa Pharmaceuticals - News, Locations, Executives and โฆ
Usearch discovered 1 location for Processa Pharmaceuticals including locations in Hanover · Maryland. Processa Pharmaceuticals is headquartered in 7380 Coca Cola Dr #106. Usearch โฆSee details»
Processa Pharmaceuticals Inc, PCSA:NAQ profile - FT.com
Mar 6, 2025 Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on utilizing its regulatory science approach, including the principles โฆSee details»
Processa Pharmaceuticals. Information about the issuer. . News โฆ
Processa Pharmaceuticals. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»
Simplification for success: Rewiring the biopharma operating model
4 days ago Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different โฆSee details»
News & Events :: Processa Pharmaceuticals, Inc. (PCSA)
Feb 7, 2025 View IR Calendar. Email Alerts. Sign up for email alerts for Press Releases & SEC Filings. Sign UpSee details»
Processa Pharmaceuticals Provides Corporate Update and โฆ
Mar 30, 2023 Company focused on the development of Next Generation Chemotherapy drugs in 2023 and out-licensing/business development efforts for non-oncology assets.See details»